Photo: STEFAN HEUNIS/AFP/Getty Images

Anheuser-Busch InBev agreed to sell its Australian operations to Japan's Asahi for $11 billion. It also is considering divestitures of its South Korea and Central America businesses.

Why it's a big deal: This is quick consequence of AB InBev canceling its Asia-Pacific IPO, whose $9 billion-plus in expected proceeds had been largely earmarked for debt reduction.

It's also yet another indictment of Warren Buffett's pals at 3G Capital, whose leverage-laden consolidation strategy for AB InBev is working out similarly at Kraft Heinz.

Bottom line: "The world’s largest brewer has struggled to cut into its debt as it confronts challenging emerging markets and declining beer consumption in key regions. In the U.S., its biggest market, AB InBev’s flagship Budweiser and Bud Light brands have lost share to rivals as consumers abandon American lagers for wine, spirits, craft beers and Mexican imports." — Jennifer Maloney & Saabira Chaudhuri, WSJ

Go deeper

Trump pushes to expand ban against anti-racism training to federal contractors

Trump speaking at Moon Township, Penns., on Sept. 22. Photo: Mandel Ngan/AFP via Getty Images

President Trump announced late Tuesday that the White House attempt to halt federal agencies' anti-racism training would be expanded to block federal contractors from "promoting radical ideologies that divide Americans by race or sex."

Why it matters: The executive order appears to give the government the ability to cancel contracts if anti-racist or diversity trainings focused on sexual identity or gender are organized. The memo applies to executive departments and agencies, the U.S. military, federal contractors and federal grant recipients.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 9:30 p.m. ET: 31,467,508 — Total deaths: 967,881— Total recoveries: 21,583,915Map.
  2. U.S.: Total confirmed cases as of 9:30 p.m. ET: 6,890,662 — Total deaths: 200,710 — Total recoveries: 2,646,959 — Total tests: 96,612,436Map.
  3. Health: The U.S. reaches 200,000 coronavirus deaths — The CDC's crumbling reputation — America turns against coronavirus vaccine.
  4. Politics: Elected officials are failing us on much-needed stimulus.
  5. Business: Two-thirds of business leaders think pandemic will lead to permanent changes — Fed chair warns economy will feel the weight of expired stimulus.
  6. Sports: NFL fines maskless coaches.
Dan Primack, author of Pro Rata
3 hours ago - Economy & Business

GoodRx prices IPO at $33 per share, valued at $12.7 billion

Illustration: Sarah Grillo/Axios

GoodRx, a price comparison app for prescription drugs at local pharmacies, on Tuesday night raised $1.14 billion in its IPO, Axios has learned.

By the numbers: GoodRx priced its shares at $33 a piece, above its $24-$28 per share offering range, which will give it an initial market cap of around $12.7 billion.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!